FDA Approved: VIGABATRIN — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin from Par Health USA, LLC under the ANDA (ANDA208218). This action represents added regulatory authorizati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Infantile Spasms
• Partial Seizures

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)